Pharmaceutical Research

, Volume 13, Issue 1, pp 163–167 | Cite as

Estimation of the Increase in Solubility of Drugs as a Function of Bile Salt Concentration

  • Sabena D. Mithani
  • Vassiliki Bakatselou
  • Christopher N. TenHoor
  • Jennifer B. Dressman


Purpose. The objective of this study was to develop a model to predict the extent to which bile salts can enhance the solubility of a drug, based on the physicochemical properties of the compound. The ability to predict bile salt solubilization of poorly soluble drugs would be a key component in determining which drugs will exhibit fed vs. fasted differences in drug absorption.

Methods. A correlation between the logarithm of the octanol/water partition coefficient [log P] of six steroidal compounds and their solubilities in the presence of various concentrations of sodium taurocholate at 37°C, log [SR] = 2.234 + 0.606log [P] (r2 = 0.987) where SR is the ratio of the solubilization capacity of the bile salt to the solubilization capacity of water for the drug, was used to predict the solubility of five further compounds with diverse structures. The solubilities of the compounds in presence of sodium taurocholate were then measured.

Results. The predicted solubilities were within 10% of the experimentally observed solubilities for griseofulvin, cyclosporin A and pentazocine. The model overpredicted the solubility of phenytoin and diazepam in 15 mM sodium taurocholate solution by a factor of 1.33 and 1.62 respectively.

Conclusions. The expected increase in solubility as a function of bile salt concentration can be estimated on the basis of the partition coefficient and aqueous solubility of the compound.

poorly soluble drugs solubility bile salts sodium taurocholate partition coefficient 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. P. Griffin. Drug interactions occurring during absorption from the gastrointestinal tract. Pharmac. Ther. 15:79–88 (1981).Google Scholar
  2. 2.
    A. Melander. Influence of food on the bioavailability of drugs. Clin Pharmacokinet. 3:337–351 (1978).Google Scholar
  3. 3.
    R. G. Crounce. Human pharmacology of griseofulvin: The effect of fat intake on gastrointestinal absorption. J. Invest. Dermatol. 37:529–532 (1961).Google Scholar
  4. 4.
    T. Hamaguchi, D. Shinkuma, T. Irie, Y. Yamanaka, Y. Morita, B. Iwamoto, K. Miyoshi, and N. Mizuno. Effect of a high-fat meal on the bioavailability of phenytoin in a commercial powder with a large particle size. Int. J. Clin. Pharmacol. Ther. Toxicol. 31(7):326–330 (1993).Google Scholar
  5. 5.
    W. N. Charman, M. C. Rogge, A. W. Boddy, and B. M. Berger. Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J. Clin. Pharmacol. 33:381–386 (1993).Google Scholar
  6. 6.
    O. Fausa. Duodenal bile acids after a test meal. Scand. J. Gastroent. 9:567–570 (1974).Google Scholar
  7. 7.
    A. Tangerman, A. vanSchaik, and E. W. vander Hook. Analysis of conjugated and unconjugated bile acids in serum and jejunal fluid of normal subjects. Clin. Chem. Acta. 159:123–132 (1986).Google Scholar
  8. 8.
    T. L. Peeters, G. Vantrappen and J. Janssens. Bile acid output and the interdigestive migrating motor complex in normals and in cholecysectomy patients. Gastroent. 79:678–681 (1980).Google Scholar
  9. 9.
    T. R. Bates, M. Gibaldi, and J. L. Kanig. Rate of dissolution of griseofulvin and hexoestrol in bile salt solutions. Nature. 210:1331–1333 (1966).Google Scholar
  10. 10.
    V. Bakatselou, R. Oppenheim, and J. Dressman. Solubilization and wetting effects of bile salts on the dissolution of steroids. Pharm. Res. 8:1461–1469 (1991).Google Scholar
  11. 11.
    L. J. M. Naylor. Dissolution mechanisms of poorly soluble compounds in simple and mixed micelle systems. Doctoral Thesis. The University of Michigan. (1993).Google Scholar
  12. 12.
    D. Shinkuma, T. Hamaguchi, M. Koboyashi, N. Mizuno, and Y. Noboru. Influence of bile on the gastrointestinal absorption of phenytoin in rats. Chem. Pharm. Bull. 33:5023–5027 (1985).Google Scholar
  13. 13.
    A. A. Noyes, and W. R. Whitney. The rate of solution of solid substances in their own solution. J. Am. Chem. Soc. 19:930–934 (1897).Google Scholar
  14. 14.
    H. Weintraub, and M. Gibaldi. Physiological surface active agents and drug absorption IV: Effect of premicellar concentrations of surfactant on dissolution rate. J. Pharm. Sci. 58:1368–1372 (1969).Google Scholar
  15. 15.
    H. Tomida, T. Yotsuyanagi, and K. Ikeda. Solubilization of steroid hormones by polyoxyethylene lauryl ether. Chem. Pharm. Bull. 26:2832–2837 (1978).Google Scholar
  16. 16.
    J. C. Caron, and B. Shroot. Determination of partition coefficients of glucocorticosteroids by high performance liquid chromatography. J. Pharm. Sci. 73:1703–1706 (1984).Google Scholar
  17. 17.
    A. Leo, C. Hansch, and D. Elkins. Partition coefficient and their uses. Chem. Rev. 71:525–616 (1971).Google Scholar
  18. 18.
    N. Taylor, A. E. Mark, P. Vallat, R. M. Brinne, B. Testa, and W. F. van Gunterent. Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporine A: evidence from partition coefficients and molecular dynamics simulations. J. Med. Chem. 36:3757–3764 (1993).Google Scholar
  19. 19.
    T. D. Wilson. Pentazocine. In Analytical Profiles of Drug Substances. vol. 13, 1984, pp. 361–416.Google Scholar
  20. 20.
    P. A. Schwartz, C. T. Rhodes, and J. W. Cooper. Solubility and ionization characteristics of phenytoin. J. Pharm. Sci. 66:994–997 (1977).Google Scholar
  21. 21.
    J. Barrett, W. F. Smyth, and I. E. Davidson. An examination of acid-base equilibria of 1,4-benzodiazepines by spectrophotometry. J. Pharm. Pharmacol. 25:387 (1973).Google Scholar
  22. 22.
    A. Osol. Remington's Pharmaceutical Sciences. 16th edition. Mack Publishing Co., Easton, Pennsylvania, 1980.Google Scholar
  23. 23.
    M. C. Carey, and D. M. Small. Micelle formation by bile salts: Physical, chemical and thermodynamic conditions. Arch. Intern. Med. 130:506–527 (1972).Google Scholar
  24. 24.
    J. B. Dressman, R. R. Berardi, L. C. Dermentzoglou, T. L. Russell, S. P. Schmaltz, J. L. Barnett, and K. M. Jarvenpaa. Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm. Res. 7:756–761 (1990).Google Scholar
  25. 25.
    D. Attwood and A. T. Florence. Surfactant Systems, Their Chemistry, Pharmacy and Biology, Chapman and Hall, London, 1983.Google Scholar
  26. 26.
    A. A. Ismail, M. Wafik Gouda, and M. M. Motawi. Micellar solubilization of barbiturates I. Solubilities of certain barbiturates in Polysorbates of varying hydrophobic chain length. J. Pharm. Sci. 59:220–224 (1970).Google Scholar
  27. 27.
    B. W. Barry and D. I. D. El Eini. Solubilization of hydrocortisone, dexamethasone, testosterone and progesterone by long chain polyoxyethylene surfactants. J. Pharm. Pharmacol. 28:210–218 (1976).Google Scholar
  28. 28.
    J. H. Collet and I. Koo. Interaction of substituted benzoic acids with polysorbate 20 micelles. J. Pharm. Sci. 64:1253–1255 (1975).Google Scholar
  29. 29.
    H. Tomida, T. Yotsuyanagi, and K. Ikeda. Solubilization of benzoic acid derivatives by polyoxyethylene lauryl ether. Chem. Pharm. Bull. 26:2824–2831 (1978).Google Scholar
  30. 30.
    K. M. S. Fahelelbom, R. F. Timoney, and O. I. Corrigan. Micellar solubilization of clofazimine analogues in aqueous solutions of ionic and nonionic surfactants. Pharm. Res. 10:631–634 (1993).Google Scholar

Copyright information

© Plenum Publishing Corporation 1996

Authors and Affiliations

  • Sabena D. Mithani
    • 1
  • Vassiliki Bakatselou
    • 1
    • 2
  • Christopher N. TenHoor
    • 1
    • 3
  • Jennifer B. Dressman
    • 1
    • 4
  1. 1.College of PharmacyThe University of MichiganAnn Arbor
  2. 2.Janssen PharmaceuticalsAthensGreece
  3. 3.Hoechst-Roussel PharmaceuticalsSomerville
  4. 4.Johann Wolfang Goethe-UniversitatFrankfurt am MainGermany

Personalised recommendations